Position
Fidelity in Entrada Therapeutics, Inc.
Back to the book · All holders of TRDA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$11.4K$12.62 → $7.36
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 16.8K | $172.9K | — | — | — | 0.0% |
| Q1 2026 | 16.9K | $213.8K | $12.62 | $39.4K | $1.53K | 0.0% |
| Q2 2026 | 2.17K | $16K | $7.36 | −$11.4K | −$186.4K | 0.0% |